Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Up 12.2% After Analyst Upgrade
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) shot up 12.2% during mid-day trading on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $32.00 to $36.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Day One Biopharmaceuticals traded as high as $17.39 and last […]
More Stories
Cadeler A/S (NYSE:CDLR) Shares Gap Up – What’s Next?
Shares of Cadeler A/S (NYSE:CDLR – Get Free Report) gapped up before the market opened on Friday . The stock...
Emera (TSE:EMA) Hits New 1-Year High – Time to Buy?
Emera Incorporated (TSE:EMA – Get Free Report) shares hit a new 52-week high on Friday . The stock traded as...
Frontline (NYSE:FRO) Shares Gap Up – Here’s What Happened
Frontline plc (NYSE:FRO – Get Free Report)’s stock price gapped up prior to trading on Friday . The stock had...
F3 Uranium (CVE:FUU) Trading Down 16.7% – Here’s What Happened
Shares of F3 Uranium Corp. (CVE:FUU – Get Free Report) fell 16.7% during mid-day trading on Friday . The stock...
SunOpta (NASDAQ:STKL) Shares Gap Up – Should You Buy?
SunOpta Inc. (NASDAQ:STKL – Get Free Report) (TSE:SOY)’s stock price gapped up before the market opened on Friday . The...
Sanatana Resources (CVE:STA) Stock Price Up 46.7% – Time to Buy?
Sanatana Resources Inc. (CVE:STA – Get Free Report) was up 46.7% on Friday . The company traded as high as...